抗疟疾耐药性的问题及其对药物发现的影响
Thomas Martin Schäfer1, Lais Pessanha de Carvalho1, Juliana Inoue1
1Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Expert opinion on drug discovery
|December 18, 2023
概括
在Plasmodium falciparum中抗疟疾药物耐药性威胁着疟疾控制. 了解耐药机制和开发具有耐药性降低潜力的新药对于未来的有效治疗至关重要.
科学领域:
- 寄生虫学的寄生虫学
- 药物耐药性机制 药物耐药性机制
- 疟疾治疗药物 疟疾治疗药物
背景情况:
- 疟疾每年造成数十万人的死亡.
- 杆菌 (Plasmodium falciparum) 的抗疟疾药物耐药性是一个持续的全球健康威胁.
- 东南亚和非洲新出现的抗药性需要紧急关注.
研究的目的:
- 为了提供一个全面的概述药物耐药性机制在Plasmodium falciparum.
- 讨论使用现有的药物减轻抗疟疾药物耐药性的策略.
- 强调开发具有抗药性降低潜力的新型抗疟疾药物的重要性.
主要方法:
- 关于Plasmodium falciparum耐药性的文献审查.
- 对抗机制的分析.
- 讨论当前和未来的抗疟疾药物战略.
主要成果:
- 对抗疟疾药物耐药性机制的详细见解.
- 评估使用已批准药物的短期策略.
- 强调需要开发新药的必要性.
结论:
- 了解耐药机制是开发新抗疟疾药物的关键.
- 虽然批准的药物可以缓解短期的耐药性,但新药的开发对于长期的疟疾控制至关重要.
- 在药物开发中纳入耐药性倾向评估可确保有效和持久的治疗方法.
更多相关视频
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.4K
10:27Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
11.7K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
